TABLE Clinical characteristics and epidemiologic risk factors among persons tested for 2019 novel coronavirus (2019-nCoV) infection (N = 210) — United States, January 2020 Characteristic Completed 2019-nCoV testing
No.* (%) Demographics Age group (yrs), median (IQR) 29 (21–49) <5 10 (5) 5–17 8 (4) 18–49 138 (66) 50–64 46 (22) ≥65 4 (2) Male sex 115 (55) Clinical features Signs or symptoms Subjective fever or measured temperature ≥100.4°F (≥38.0°C) 143 (68) Cough or shortness of breath 189 (90) Clinical Course Hospitalized 42 (20) Admitted to ICU 4 (2) Died† 1 (<1) Setting where patient identified Airport screening 6 (3) Health care setting 178 (85) Contact tracing§ 26 (12) Epidemiologic risk category Travel from China¶ 148 (70) Close contact with an ill laboratory-confirmed 2019-nCoV patient or a PUI in the United States** 42 (20) Travel from China and close contact identified†† 18 (9) Other risk§§ 2 (<1) Abbreviations: ICU = intensive care unit; IQR = interquartile range; PUI = person under investigation. * Numbers might not sum to total because of missing data. † For this person, testing was negative for 2019-nCoV, and an alternative cause of death was established. § Additional persons who were being followed through contact tracing but initially sought treatment at a health care setting are not included in this category. ¶ Includes 113 persons who traveled from Wuhan City and 35 who traveled from areas of China outside Wuhan within 14 days of symptom onset. ** Includes 33 persons who were close contacts of an ill laboratory-confirmed 2019-nCoV patient and nine who were close contacts of PUIs. All contacts occurred within 14 days of symptom onset. †† Includes four persons who traveled from Wuhan City and were close contacts of an ill laboratory-confirmed 2019-nCoV patient, 11 who traveled from Wuhan City and were close contacts of PUIs, and three who traveled from China and were close contacts of a PUI. §§ Had possible contact with a laboratory-confirmed 2019-nCoV patient and were therefore tested.